NCT06254794 Effect of BFR Rehab After Achilles Tendon Rupture
| NCT ID | NCT06254794 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Methodist Hospital Research Institute |
| Condition | Achilles Tendon Rupture |
| Study Type | INTERVENTIONAL |
| Enrollment | 19 participants |
| Start Date | 2018-11-13 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 19 participants in total. It began in 2018-11-13 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine if blood flow restriction therapy after Achilles tendon rupture reconstruction decreases post-operative calf atrophy, improves reported outcomes, and ultimately decreases return to play time.
Eligibility Criteria
Inclusion Criteria: * Achilles Rupture confirmed by MRI or Thompson Test * Adult * Receiving Percutaneous Achilles Repair System (PARS) or open repair * Proposed PT with Methodist Location Exclusion Criteria: * Obesity (BMI\>35) * Diabetes * Cardiovascular, renal, liver or pulmonary disease * Active infections * Cancer (current or treated within the past 2 years) or coagulation disorder * Physically unable to participate in the intervention * Unable to complete a minimum of 85% of the assigned rehabilitation sessions * Less than 18 years of age * Pregnant
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06254794 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Achilles Tendon Rupture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06254794 currently recruiting?
Yes, NCT06254794 is actively recruiting participants. Contact the research team at hmgoble@houstonmethodist.org for enrollment information.
Where is the NCT06254794 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06254794 clinical trial?
NCT06254794 is sponsored by The Methodist Hospital Research Institute. The trial plans to enroll 19 participants.